Boehringer Ingelheim International GmbH, ViiV Healthcare, Merck & Co., Inc., F. Hoffmann-La Roche Ltd., Gilead Sciences, Inc., Cipla Inc., and Johnson & Johnson Services, Inc., among others, are the major players in the global HIV drugs market.
The global HIV drugs market attained a value of about USD 24.3 billion in 2020. The industry is further projected to decline at a CAGR of about 2.4% in the forecast period of 2021-2026 to reach a value of around USD 22.1 billion by 2026. As per the analysis by Expert Market Research, the market is expected to be driven by the growing development and introduction of HIV drugs.
The market is being driven by the increasing government initiatives and campaigns, surging population density of HIV infected people, and the introduction of generic drugs in the market. Furthermore, international organisations' rising investments in R&D activities to develop efficient therapeutic solutions and advanced treatment options are aiding the industry. The industry is boosted by the presence of established healthcare facilities in North America.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The major players in the global HIV drugs market include ViiV Healthcare, Merck & Co. (NYSE: MRK) and Gilead Sciences, Inc. (NASDAQ: GILD). Gilead Sciences, Inc. and Merck & Co. signed an agreement in March 2021 to co-develop and co-commercialise the long-term treatment for HIV. The two companies' collaboration will provide new treatment options for HIV patients by further developing Gilead's lenacapavir and Merck's islatravir. ViiV Healthcare, in January 2021, announced the FDA approval of Cabenuva, the first and the only complete long-acting treatment for HIV-1 in adults. The drug provides virologically suppressed adults with HIV to sustain viral suppression with 12 dosing days annually. The development of innovative, inexpensive, reliable, and efficient medicines for treating HIV is aiding the market.
Headquarters: Ingelheim am Rhein, Germany
Boehringer Ingelheim International GmbH is a German pharmaceutical company that develops, produces and markets products of superior therapeutic value for human and veterinary medicine. The products offered by the company include Giotrif, Jardiance, OFEV, Pradaxa, Praxbind, Spiriva, and many others. It is a global leader in the prevention of diseases through vaccines and parasiticides. The company generated a revenue of about EUR 19,556 million in 2020.
Headquarters: North Carolina, USA
ViiV Healthcare is a UK-based pharmaceutical company that was formed as a joint venture by Pfizer and GlaxoSmithKline for developing therapies for HIV disease. The company provides 16 antiretroviral medicines and a range of therapeutic options for HIV treatment. It is the second-largest healthcare company engaged in providing treatment for HIV globally. ViiV Healthcare has about 1000 employees working in 15 countries and three regional hubs.
Headquarters: New Jersey, United States of America
Merck & Co., Inc is an American multinational company and provides vaccinations and medicines for treating cancer, oncology, cardio-metabolic disorders, infectious diseases, HIV and Ebola, and emerging animal diseases. The company had invested over USD 13.6 billion in 2020 for research and development on finding solutions for various diseases. Merck & Co., Inc has about 74,000 employees globally. The company earned USD 47,994 million in 2020.
Headquarters: Basel, Switzerland
F. Hoffmann-La Roche Ltd is a Switzerland-based healthcare company and is the largest biotech company globally. The company is a global leader in providing in vitro diagnosis and cancer drugs and operates under two divisions: pharmaceuticals and diagnostics. The subsidiaries under it are Genentech, GenMark Diagnostics, Chugai Pharmaceutical Co, Spark Therapeutics, and others. It provides medicines for oncology, virology, inflammation, metabolism, blood screening, genetics, infectious diseases, and others. The company generated CHF 61,466.00 million in 2019.
Headquarters: California, United States of America
Gilead Sciences, Inc. is an American biopharmaceutical company that develops and distributes therapeutics for patients suffering from severe diseases. The company offers medicines for HIV, AIDS, liver disease, oncology, COVID-19, and serious cardiovascular and respiratory conditions. These medicines include Atripla®, Biktarvy®, Descovy®, Veklury®, Viread®, Trodelvy™ and many others. The company generated product sales of USD 6.3 billion in Q1 2021.
Headquarters: Mumbai, India
Cipla Inc. is an Indian pharmaceutical company that provides medicines and personal care products. The company produces active pharmaceutical ingredients and formulations in therapeutic areas, such as allergy, analgesic, anti-malarial, anti-infectives, cardiology, dermatology and cosmeceuticals, diabetology, gastroenterology, steroids, iron chelators and nutritional products. It develops over 1,500 products and has a presence in about 80 countries globally.
Headquarters: New Jersey, United States of America
Johnson & Johnson Services Inc is a subsidiary of Johnson & Johnson. The company operates in more than 60 countries. It offers consumer healthcare products for hygiene, beauty, facial skin care, baby care, wound care, cough and cold, and over-the-counter products. With over 130,000 employees, the company generated worldwide sales of USD 82.584 billion in 2020.
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.